Compare Neurocrine Biosciences Inc (NBIX) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Oxford Lane Capital Corp — how do they compare? Neurocrine Biosciences Inc trades at $158.83 (market cap $16.46B), while Oxford Lane Capital Corp trades at $9.42 (market cap $909.61M). The key difference: Neurocrine Biosciences Inc is far larger — about 18.1× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays a 25.76% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | OXLC | |
|---|---|---|
Market Cap | $16.46B | $909.61M |
Sector | Health | Financials |
52-Week High | $185.50 | $18.75 |
52-Week Low | $123.10 | $8.15 |
Enterprise Value | $16.48B | — |
Dividend Yield | — | 25.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
